CIBC Maintains Outperformer on Nutrien, Lowers Price Target to $88

Benzinga Newsdesk www.benzinga.com Negative 92.7%

Neg 92.7% Neu 0% Pos 0%

CIBC analyst Hamir Patel maintains Nutrien (NYSE:NTR) with a Outperformer and lowers the price target from $90 to $88.

Comments

No comments yet. Be the first!